Sorafenib and dacarbazine in soft tissue sarcoma: a single institution experience.
about
Targeted therapy in sarcomas other than GIST tumorsDiarrhea as initial manifestation of pulmonary artery intimal sarcoma: a case report and literature review.Antiangiogenic approach in soft-tissue sarcomas.Do anti-angiogenic cancer therapies increase risk of significant weight loss?Targeted polytherapy in small cell sarcoma and its association with doxorubicin.
P2860
Sorafenib and dacarbazine in soft tissue sarcoma: a single institution experience.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Sorafenib and dacarbazine in soft tissue sarcoma: a single institution experience.
@ast
Sorafenib and dacarbazine in soft tissue sarcoma: a single institution experience.
@en
type
label
Sorafenib and dacarbazine in soft tissue sarcoma: a single institution experience.
@ast
Sorafenib and dacarbazine in soft tissue sarcoma: a single institution experience.
@en
prefLabel
Sorafenib and dacarbazine in soft tissue sarcoma: a single institution experience.
@ast
Sorafenib and dacarbazine in soft tissue sarcoma: a single institution experience.
@en
P2093
P2860
P50
P1476
Sorafenib and dacarbazine in soft tissue sarcoma: a single institution experience.
@en
P2093
Gaia Schiavon
Marianna Silletta
Raimondo Del Vescovo
P2860
P356
10.1517/13543784.2013.742886
P407
P50
P577
2012-11-16T00:00:00Z